Downloaded 24 times
Uploaded byLevi Shapiro
mHealth Israel_Gil Bashe- NAVIGATING THE MAZE- US PROVIDER SYSTEMS HAVE MULTIPLE DECISION MAKERS
1. Promoting medical research through clinical trials aligns with the mission of hospitals by resulting in better patient care and faster development of new treatments over the long run, without requiring hospitals to change their operations. 2. Successfully navigating the complex healthcare ecosystem requires understanding how economic factors influence decisions across stakeholders like product uptake, technology adoption, and supporting patient care. 3. While engaging a major medical institution may seem like the clear mission, the reality is a complex system with many layers of decision makers that a physician champion must convince beyond just their department chair, like nursing, procurement, risk management, and operations leadership.
More Related Content
Similar to mHealth Israel_Gil Bashe- NAVIGATING THE MAZE- US PROVIDER SYSTEMS HAVE MULTIPLE DECISION MAKERS
mHealth Israel_Gil Bashe- NAVIGATING THE MAZE- US PROVIDER SYSTEMS HAVE MULTIPLE DECISION MAKERS
- 1. 1 NAVIGATING THE MAZE USPROVIDER SYSTEMS HAVE MULTIPLE DECISION MAKERS
- 2. 2 THE IMPORTANCE OFCLINICAL TRIALS AND HOSPITALS “The primary focus for community healthcare institutions will always be providing care for their patients, and sometimes, research is perceived as an impediment to that focus because without dedicated research teams, it can cause increased workload on the hospital personnel. Luckily, it doesn't. At least, it doesn't have to. For one, promoting medical advances and giving patients access to research already align with the mission of hospitals because in the long run, those efforts result in better care for patients. They will result in faster development of new medicines and treatments, too — all while not requiring hospitals to change what they do or how they do it. It's a win for all stakeholders.”
- 3. TO SUCCEED, YOUWILL NEED TO NAVIGATE THE COMPLEX HEALTH ECOSYSTEM You must understand how economics influence health stakeholder decisions, product uptake, brand expansion, technology transformation and the journey to support patient care. Being inside an academic system with research does not guarantee sales uptake. It’s not enough to save lives and reduce costs! GOVERNMENT/ REGULATORS & POLICY MAKERS PRODUCT INNOVATORS HEALTHCARE CONSUMERS, PATIENTS & CAREGIVERS MEDICAL DEVICE & DIAGNOSTICS COMPANIES
- 4.
- 5. THE MISSION SEEMSCLEAR – ENGAGE ONE MAJOR INSTITUTION
- 6. REALITY – IT’SA COMPLEX MAZE WITH LAYERS OF DECISION MAKERS
- 7. CLINICAL TRIALS ANDDATA DEFINE THE WINDOW OF VALUE – BUT… “Demonstrating value requires a deep understanding of the clinical benefit and costs, not only of the therapy but also of the complete care received by the patient. Evidence from both clinical trials and patients treated in the real world is necessary to show payers how clinical benefits translate into reduced or minimal changes in costs, because real-world patients can be remarkably different, both demographically and clinically, compared to clinical trial participants.”
- 8. IT’S ONE BRAND,ONE LOCATION, AND A MYRIAD OF DECISION MAKERS PHYSICIAN CHAMPION IS ESSENTIAL; HOWEVER, THE CHAMPION MUST WIN-OVER OTHERS Chief of Nursing Chief Procurement Officer Risk ManagementDepartment Chair Chief Operating Officer
- 9. A CHAMPION CHECKLISTMUST... DEMONSTRATE PROOF CONVEY VALUE MEET EASE OF IMPLEMENTATION FIT AN ECONOMIC MODEL